Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
South Korea · Delayed Price · Currency is KRW 30,700
+350 (1.15%)
Feb 20, 2026, 3:30 PM KST
18.53% (1Y)
| Market Cap | 180.52B +17.6% |
| Revenue (ttm) | 209.00B +3.5% |
| Net Income | 31.56B +2.9% |
| EPS | 5,366.74 +2.9% |
| Shares Out | 5.88M |
| PE Ratio | 5.72 |
| Forward PE | 5.93 |
| Dividend | 900.00 (2.97%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 27,734 |
| Average Volume | 18,178 |
| Open | 30,400 |
| Previous Close | 30,350 |
| Day's Range | 30,100 - 30,900 |
| 52-Week Range | 24,750 - 33,950 |
| Beta | 0.16 |
| RSI | 67.47 |
| Earnings Date | Mar 18, 2026 |